Newsroom | 196608 results

KAILUA-KONA, Hawaii--(BUSINESS WIRE)--Science has evolved for smarter sun care. BioAstin® Hawaiian Astaxanthin® delivers clinically backed sun support from within with powerful microalgae....

LYON, France--(BUSINESS WIRE)--MaaT Pharma Provides a Business Update and Highlights Key Milestones Expected in 2025...

AURORA, Ill.--(BUSINESS WIRE)--Simplify Healthcare, a recognized leader in enterprise software solutions for Payers, today announced Xperience1™, a groundbreaking solution designed to transform the benefits inquiry experience for health plan members, providers, brokers, and other stakeholders. This next-generation CX platform delivers clear, real-time, plain-language responses to complex benefit questions—across all channels and user roles. Built on the trusted Simplify Health Cloud™, Xperience...

DUBLIN--(BUSINESS WIRE)--The "In-vitro Diagnostics (IVD) Reagents Market - Global Outlook & Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The In-vitro Diagnostics (IVD) Reagents Market was valued at USD 77.56 Billion in 2024, and is projected to reach USD 96.17 Billion by 2030, rising at a CAGR of 3.65% The report considers the present scenario of the global IVD reagents market and its market dynamics for 2025-2030. It covers a detailed overview of several...

CHICAGO--(BUSINESS WIRE)--Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentions being the development and research of innovative total body PET/CT technology.i This effort is expected to explore new clinical pathways and help enhance patient outcomes through innovative imaging solutions. “PET/CT has revolutionized the way we understand and treat disease by allowing us to visu...

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including Metabolic dysfunction-Associated SteatoHepatitis (MASH) and rare metabolic disorders, today announces that five presentations in relation to the potential of Imeglimin, marketed under the brand name TWYMEEG® in Japan, will be made at the 85th Scientific Sessio...

PARME, Italie--(BUSINESS WIRE)--Chiesi Global Rare Diseases, une unité commerciale de Chiesi Group créée pour proposer des solutions innovantes aux personnes atteintes de maladies rares, a annoncé aujourd’hui les lauréats de son programme de subventions de recherche « Find For Rare ». Cette initiative de bourses de recherche évaluée de manière indépendante et dirigée par des experts vise à améliorer les soins et la prise en charge des patients en récompensant la recherche innovante dans trois m...

PARMA, Italië--(BUSINESS WIRE)--Chiesi Global Rare Diseases, een bedrijfsonderdeel van de Chiesi Group opgericht om innovatieve oplossingen te leveren voor mensen die een zeldzame aandoening hebben, kondigde vandaag de ontvangers aan van zijn "Find For Rare" onderzoekssubsidieprogramma. Het onafhankelijk beoordeelde, door experts geleide onderzoekssubsidie-initiatief beoogt om de behandeling en de zorg voor patiënten te verbeteren door innovatief onderzoek te erkennen in drie lysosomale ziektes...

DUBLIN--(BUSINESS WIRE)--The "Health & Wellness Spa Market - Focused Insights 2025-2030" report has been added to ResearchAndMarkets.com's offering. The Health & Wellness Spa Market was valued at USD 124.23 Billion in 2024, and is projected to reach USD 173.74 Billion by 2030, rising at a CAGR of 5.75% The global health & wellness spa market report consists of exclusive data on 38 vendors. The market is highly competitive with many local and international players in the market. Day...

GOLDEN, Colo.--(BUSINESS WIRE)--Agreement with Immuno Cure adds to PharmaJet's portfolio of global development partnerships with innovative oncology & infectious disease developers....